Offer - Urjas Oil for just ₹ 1
Elcapon 50/12.5/200 Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Elcapon 50/12.5/200 Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Elcapon 50/12.5/200 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Elcapon 50/12.5/200 Tablet include Nausea or vomiting, Headache, Infection. Apart from the aforementioned side effects, Elcapon 50/12.5/200 Tablet can also lead to other problems, which have been listed below. These side effects of Elcapon 50/12.5/200 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Elcapon 50/12.5/200 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. In addition, Elcapon 50/12.5/200 Tablet's effects on the liver, heart and kidney are discussed below in the Elcapon 50/12.5/200 Tablet related warnings section.
Elcapon 50/12.5/200 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Elcapon 50/12.5/200 Tablet in conditions like Arrhythmia, Low Blood Pressure (Hypotension), Depression. Other conditions have been mentioned below in the Elcapon 50/12.5/200 Tablet contraindications section.
Besides this, Elcapon 50/12.5/200 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Elcapon 50/12.5/200 Tablet is not safe while driving, and is is not addictive in nature.
Elcapon 50/12.5/200 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Elcapon 50/12.5/200 Tablet safe for pregnant women?
Elcapon can have harmful effects in pregnant women. If you experience any discomfort after using Elcapon, then discontinue the use and take your doctor's advice.
Is the use of Elcapon 50/12.5/200 Tablet safe during breastfeeding?
Elcapon may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Elcapon 50/12.5/200 Tablet on the Kidneys?
Elcapon rarely affects the kidneys.
What is the effect of Elcapon 50/12.5/200 Tablet on the Liver?
Very few cases of side effects of Elcapon on the liver have been reported.
What is the effect of Elcapon 50/12.5/200 Tablet on the Heart?
There are no any side effects of Elcapon for the heart.
If you are suffering from any of the following diseases, you should not take Elcapon 50/12.5/200 Tablet unless your doctor advises you to do so -
Is this Elcapon 50/12.5/200 Tablet habit forming or addictive?
Forming a habit of Elcapon 50/12.5/200 Tablet has not been reported.
Interaction between Food and Elcapon 50/12.5/200 Tablet
Elcapon 50/12.5/200 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Elcapon 50/12.5/200 Tablet
Taking alcohol with Elcapon 50/12.5/200 Tablet can be dangerous.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 426-429
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 54-55
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 279-281
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 429-430
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lodosyn® (carbidopa)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sinemet® (carbidopa-levodopa)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rytary® (carbidopa-levodopa)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 498
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 432
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Comtan® (entacapone)
